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pump CABG surgery appeared to remain absent at 5 years. These
findings suggest that factors other than cardiopulmonary bypass
may be responsible for cognitive decline, such as anesthesia and
the generalized inflammatory response that is associated with
major surgical procedures.1,4
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Primary Sjogren syndrome (pSS) is an autoimmunecondition characterized by exocrine gland involve-ment resulting in dryness of the eyes and mouth andextraglandular manifestations. It is associated with a
44-fold increased risk for the development of non-Hodgkin
lymphoma.1 Lymphoma develops in approximately 4% of pa-
tients with pSS, which manifests in diverse nodal and extran-
odal sites such as the salivary glands, stomach, lung, and
adrenal glands.2 This would be the first reported case of pSS-
related cardiac lymphoma. The lymphoma was initially con-
fined to the heart but rapidly progressed. The importance of
early appropriate radiologic and surgical intervention is high-
lighted.
Clinical Summary
An 84-year-old Chinese woman presented with increasing dys-
pnea associated with weight loss. She had mild arthritis and
dryness of the eyes and mouth for approximately 10 years. She
was a nonsmoker and had no family history of cardiac illnesses.
On examination, the heart sounds were muffled and jugular
venous pressure was increased. Systemic examination results
were otherwise unremarkable. The results of investigations
were as follows (reference ranges in parentheses): Hemoglobin
was 9.6 g/dL (12.0 –16.0); white cell count and platelet count
were normal. Erythrocyte sedimentation rate was 96 mm/h
(3–20), and C-reactive protein was 26.3 mg/L (0.2– 8.8).
Schirmer’s I test was positive at 2 mm (5 mm). Anti-Ro and
La antibodies were present. Anti-dsDNA, Smith, ribonucleo-
protein, Scl-70, and cardiolipin antibodies were not present.
Serum complements C3 and C4, urea and electrolytes, liver
enzymes, bone and thyroid profile, rheumatoid factor, and im-
munoglobulins G, A, and M were unremarkable. A computed
tomographic (CT) scan and an echocardiographic scan showed
a large pericardial effusion, with no other abnormality detected.
Needle pericardiocentesis yielded nonhemorrhagic pericardial
fluid that was negative for malignant cells and organism growth,
including tuberculosis. A minor salivary gland biopsy was not
performed because the classification criteria for pSS had been
fulfilled.2 pSS, with symptomatic pericardial effusion, was
therefore diagnosed.
However, despite corticosteroid treatment for presumed
pSS-related inflammatory pericardial effusion, our patient was
readmitted to the hospital for dyspnea less than 1 week after
discharge. A cardiac magnetic resonance imaging scan showed
recurrence of the pericardial effusion with 2 previously unde-
tected small biventricular lesions confined to the pericardium
and intrapericardial space. An urgent therapeutic pericardial
window was created that revealed a small plaque-like epicardial
mass over the right ventricle. Histopathologic analysis of the
lesion showed a diffuse pattern of large cells with amphophilic
cytoplasm and eccentric nuclei with obvious nucleoli, resem-
bling immunoblasts admixed with smaller cells with folded
nuclei and multiple nucleoli. The cells were positive for CD20
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and bcl2, and demonstrated a proliferation index of 80% with
Ki67 but were negative for CD3 and cytokeratin (MNF116).
The features were consistent with CD20-positive diffuse large
B-cell lymphoma (DLBCL). At this point, our patient declined
chemotherapy because of frailty. Subsequent clinic review
showed new findings of enlarged parotid glands and a left breast
mass. A CT scan performed 4 weeks after the diagnosis of
primary cardiac lymphoma revealed progression of disease with
the involvement of intra-abdominal nodes and left breast but no
lung involvement. Bone marrow examination was unremark-
able. Biopsy of the breast mass confirmed CD20-positive DL-
BCL.
Discussion
DLBCLs are aggressive tumors, and the early commencement
of a chemotherapy regimen that includes rituximab yields better
outcomes.3 With the patient’s eventual consent, treatment com-
prising rituximab, cyclophosphamide, vincristine, and high-
dose prednisone was initiated. After 4 courses of chemotherapy,
there has been clinical improvement with return of normal
appetite, weight gain, and no breathlessness or chest pain.
Follow-up CT scans of the neck, thorax, and abdomen suggest
good response to treatment with reduction of abnormal thick-
ened pericardium and almost complete resolution of widespread
lymphadenopathy.
Cardiac lymphoma is rare and tends to occur in human immu-
nodeficiency virus-positive individuals. Our patient had pSS but
was human immunodeficiency virus negative. Primary cardiac
lymphoma may be low grade;4 however, as highlighted in this
brief communication, it may be insidious but aggressive and occur
in preexisting nononcologic syndromes, such as pSS. Diagnosis of
cardiac lymphoma requires a high index of suspicion. Echocardio-
graphic evidence of clinically silent cardiac involvement in pSS is
common. However, Mita and colleagues5 found that 21.2% of
patients with pSS had pericardial effusions that rarely caused
symptoms.
In patients with pSS with symptomatic pericardial effusions,
prompt evaluation with cardiac magnetic resonance imaging or
positron emission tomographic scans for lymphoma should be
considered because of significant disease association that may not
be initially evident on echocardiography or pericardial fluid anal-
yses. Urgent pericardial window creation and biopsy of the poten-
tially occult plaque-like cardiac lesion for therapeutic and diag-
nostic purposes in our patient were imperative for optimal
outcome.
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